FOUR GENERATIONS COMMITTED TO OVERCOMING INFECTIOUS DISEASES
Marcel Mérieux, a student of Louis Pasteur, creates the Institut Biologique Mérieux.
Dr. Charles Mérieux
Dr. Charles Mérieux succeeds his father Marcel. He launches production of the foot-and-mouth disease vaccine. This marks the birth of industrial virology.
Dr. Charles Mérieux creates IFFA (Institut Français de Fièvre Aphteuse).
Alain Mérieux creates BD Mérieux, an in vitro diagnostics company jointly owned by Institut Mérieux and Becton Dickinson.
Dr. Charles Mérieux creates Fondation Mérieux.
Alain Mérieux succeeds his father as the head of Institut Mérieux, which will become a world leader in the field of human and veterinary vaccines.
Groupe Rhône-Poulenc acquires a stake in Institut Mérieux.
Alain Mérieux takes over BD Mérieux which becomes bioMérieux.
Institut Pasteur Production
Institut Mérieux acquires Institut Pasteur Production (vaccines).
bioMérieux acquires API Systems (bacterial identification).
bioMérieux acquires Vitek Systems (bacterial identification and susceptibility testing automation) from McDonnell Douglas, a North American company.
Institut Mérieux acquires Connaught Laboratories (vaccines)
Divestment of vaccine business
The Mérieux family divests from its vaccine business (Rhône-Poulenc buys Institut Mérieux, which includes Pasteur Mérieux Sérums et Vaccins and Rhône Mérieux, now Sanofi Pasteur and Merial).
The Mérieux family takes control of Transgene (immunotherapy).
Stock market listing
Transgene is listed on the stock exchange.
The Mérieux family holding company takes control of Silliker Group Corporation (food safety).
bioMérieux acquires Organon Teknika (diagnostics).
The Mérieux family holding company acquires ABL Inc. (CRO)
Fondation Rodolphe Mérieux
Creation of Fondation Rodolphe Mérieux (which will become Fondation Christophe et Rodolphe Mérieux in 2006).
Stock market listing
bioMérieux is listed on the stock market (Euronext Paris).
Launch of the ADNA program on personalized medicine supported by the French government.
The Mérieux Alliance holding company changes its name to Institut Mérieux to revive the historic name.
Creation of Mérieux Développement (Investment company).
Mérieux Research Grants
Launch of the international innovation program Mérieux Research Grants.
Development of the nutrition/health unit Mérieux NutriSciences.
bioMérieux acquires BioFire (syndromic diagnostics).
Alexandre Mérieux becomes CEO of bioMérieux.